Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cells

Immunobiology

Volumn 201, Issue 3-4, 2000, Pages 478-491

  Spöttl, Natalie ^a   Wirlettner, Barbara ^a   Böck, Günther ^b   Widner, Bernhard ^a   Fuchs, Dietmar ^a   Baier Bitterlich, Gabriele ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOPTERIN; FOLIC ACID DERIVATIVE; NEOPTERIN; PTERIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL LINE; CELL SURVIVAL; HUMAN; HUMAN CELL; NERVE CELL; PRIORITY JOURNAL;

EID: 19244368863     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(00)80100-X     Document Type: Article

References (48)

1. BROWN, G. M. 1971. The biosynthesis of pteridines. Adv. Enzymol. 35: 5.
2. BROWN, G. M., and J. M. WILLIAMSON. 1982. Biosynthesis of riboflavin, folic acid, thiamin, and pantothenic acid. Adv. Enzymol. 53: 345.
3. RICHTER, G., H. RITZ, G. KATZENMEIER, R. VOLK, A. KOHNLE, F. LOTTSPEICH, D. ALLENDORF, and A. BACHER. 1993. Biosynthesis of riboflavin-cloning, sequencing, mapping, and expression of the gene coding for GTP cyclohydrolase-II in Escherichia coli. J. Bacteriol. 175: 4045.
4. WERNER, E. R., G. WERNER-FELMAYER, H. WACHTER, and B. MAYER. 1995. biosynthesis of nitric oxide: Dependence on Pteridine metabolism. Rev. Physiol. Biochem. Pharmacol. 127: 97.
5. KAUFMAN, S. 1963. The structure of phenylalanine hydroxylation cofactor. Proc. Natl. Acad. Sci. U.S.A. 50: 1085.
6. TAYEH, M. A., and M. A. MARLETTA. 1989. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. J. Biol. Chem. 264: 19654.
7. WERNER-FELMAYER, G., E. R. WERNER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, and H. WACHTER. 1990. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J. Exp. Med. 172: 1599.
8. HUBER, C., J. R. BATCHELOR, D. FUCHS, A. HAUSEN, A. LANG, D. NIEDERWIESER, G. REIBNEGGER, P. SWETLY, J. TROPPMAIR, and H. WACHTER. 1984. Immune response-associated production of neopterin J. Exp. Med. 160: 310.
9. BITTERLICH, G., G. SZABO, E. R. WERNER, C. LARCHER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, T. F. SCHULZ, J. TROPPMAIR, and H. WACHTER. 1988. Selective induction of mononuclear phagocytes o produce neopterin by interferons. Immunobiol. 176: 228.
10. FUCHS, D., S. MILSTIEN, A. KRÄMER, G. REIBNEGGER, E. R. WERNER, J. J. GOEDERT, S. KAUFMAN, and H. WACHTER. 1989. Urinary neopterin concentrations vs. total neopterins for clinical utility. Clin. Chem. 35: 2305.
11. FAHEY, J. L., J. M. G. TAYLOR, R. DETELS, B. HOFMANN, R. MELMED, P. NISHANIAN, and J. V. GIORGI. 1990. The prognostic value of cellular and serologic markers in infection with Human Immunodeficiency Virus Type 1. N. Engl. J. Med. 322: 166.
12. REIBNEGGER, G., V. BOONPUCKNAVIG, D. FUCHS, A. HAUSEN, E. SCHMUTZHARD, H. WACHTER. 1984. Urinary neopterin is elevated in patients with malaria. Trans. Roy. Soc. Trop. Med. Hyg. 78: 545.
13. BROWN, A. E., D. A. B. DANCE, W. CHAOWAGUL, H. K. WEBSTER, and N. J. WHITE. 1990. Activation of cellular immune responses in melipoidosis patients as assessed by urinary neopterin. Trans. Roy. Soc. Trop. Med. Hyg. 84: 583.
14. REIBNEGGER, G., D. EGG, D. FUCHS, R. GÜNTHER, A. HAUSEN, E. R. WERNER, and H. WACHTER. 1986. Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Arthrit. Rheumat. 29: 1063.
15. LEOHIRIN, L., P. THUVASETAKUL, V. SUMETHKUL, T. PHOLCHAROEN, V. BOONPUCKNAVIG. 1991. Urinary neopterin in patients with systemic lupus erytheatosus. Clin. Chem. 37: 47.
16. REIBNEGGER, G., D. FUCHS, L. FURTH, A. HAUSEN, E. R. WERNER, G. WERNER-FELMAYER, and H. WACHTER. 1991. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect. Prev. 15: 483.
17. LEBLHUBER, F., J. WALLI, G. P. TILZ, H. WACHTER, and D. FUCHS. 1998. Systemische Veränderungen des Immunsystems by Patienten mit Alzheimer-Demenz. Dtsch. Med. Wschr. 123: 787.
18. HAGBERG, L., L. DOTEVALL, G. NORKRANS, M. LARSSON, H. WACHTER, and D. FUCHS. 1993. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J. Inf. Diseases 168; 1285.
19. WEISS, G., K. GLASER, P. KRONBERGER, E. AMBACH, D. FUCHS, E. BODNER, and H. WACHTER. 1992. Distinct distributions of D-erythro-neopterin in arteries and veins and its recovery by an enterohepatic circulation. Biol. Chem. Hoppe-Seyler 373: 289.
20. LEVINE, R. A., and S. MILSTIEN. 1984. The ratio of reduced to oxidized neopterin and biopterin in human fluids: significance to the study of human disease. In: Biochemical and Clinical Aspects of Pteridines (PFLEIDERER, W. H. WACHTER, and H.-C. CURTIUS, eds.) Walter de Gruyter, Berlin-New York, vol. 3: pp. 277.
21. BREW, B. J., R. B. BHALLA, M. PAUL, H. GALLARDO, J. C. MCARTHUR, M. K. SCHWARTZ, and R. W. PRICE. 1990. Cerebrospinal fluid neopterin in Human Immunodeficiency Virus Type 1 infection. Ann. Neurol. 28: 556.
22. GRIFFIN, D. E., J. C. MCARTHUR, and D. R. CORNBLATH. 1991. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 41: 69.
23. NATHAN, C. F. 1986. Peroxide and pteridine: a hypothesis on the regulation of macrophage antimicrobial activity by interferon y. In: Interferon 7 (GRESSER, I., and L. VICEK, eds.) ACADEMIC PRESS, LONDON 125.
24. FUCHS, D., G. BAIER-BITTERLICH, I. WEDE, and H. WACHTER. 1997. Reactive Oxygen and Apoptosis. In Oxidative Stress and the Molecular Biology of Antioxidant Defenses (Cold Spring Harbor Press. Scandalios JG, ed.).
25. BAIER-BITTERLICH, G., D. FUCHS, and H. WACHTER. 1997. Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem. Pharmacol. 53: 755.
26. BREDESEN, D. E. 1999. The emerging relationship between developmental and degenerative neural cell death. Neural Notes 4: 3.
27. GEHRMANN, J., Y. MATSUMOTO, and G. W. KREUTZBERG. 1996. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 20: 269.
28. GEHRMANN, J., R. B. BANATI, C. WIESSNER, K. A. HOSSMANN, and G. W. KREUTKBERG. 1995. Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol. Appl. Neurobiol. 21: 277.
29. GIULIAN, D., K. VACA, and M. CORPUZ. 1993. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13: 29.
30. GIULIAN, D., L. J. HAVERKAMP, J. LI, W. L. KARSHIN, J. YU, D. TOM, X. LI, and J. B. KIRKPATRICK. 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27: 119.
31. GORMAN, A. M., A. MCGOWAN, C. O'NEIL, and T. COTTER. 1996. Oxidative stress and apoptosis in neurodegeneration. J. Neurol. Sci. 139: 45.
32. WERNER, E. R., G. WERNER-FELMAYER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, and H. WACHTER. 1989. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cell sand cell lines by interferon-γ. Biochem. J. 262: 861.
33. PLEASURE, S. J., C. D. PAGE, and V. M.-Y. LEE, 1992. Pure, postmitotic polarized human neurons derived from NTera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12: 1802.
34. NICOLETTI, I., G. MIGLIORATI, M. C. PAGLIACCI, F. GRIGNANI, and C. RICCARDI. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271.
35. SGONC, R., and G. WICK. 1994. Methods for the detection of apoptosis. Int. Arch. Allergy and Immunol. 105: 327.
36. KANE, D. J., T. A. SARAFIAN, R. ANTON, H. HAHN, E. BUTLER GRALLA, J. SELVERSTONE VALENTINE, T. ÖRD, and D. E. BREDESEN. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274.
37. KUIPER, M. A., J. J. VISSER, P. L. M. BERGMANS, P. SCHELTENS, and E. C. WOLTERS. 1994. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy. J. Neurol. Sci. 121: 46.
38. WACHTER, H., D. FUCHS, A. HAUSEN, G. REIBNEGGER, E. WEISS, E. R. WERNER, and G. WERNER-FELMAYER. 1992. Neopterin. Walter de Gruyter (Berlin, New York).
39. PEARSON, A. J. 1974. Kinetics and mechanisms of the autooxidation of tetrahydropterins. Chemistry and Industry 233.
40. ROBERTS, P. J., G. A. FOSTER, and E. M. THOMAS. 1981. Neurotoxic of methyltetrahydrofolate in rat cerebellum unrelated to direct activation of kainate receptors. Nature 293: 654.
41. OLNEY, J. W., T. A. FULLER, and T. DE GUBAREFF. 1981. Kainate-like neurotoxicity of folates. Nature 292: 16.
42. TREMBLAY, E., M. BERGER, L. NITECKA, E. CAVALHEIRO, and Y. BEN-ARL. 1984. A multidisciplinary study of folic acid neurotoxicity: interactions with kamate binding ites and relevance to the aetiology of epilepsy. Neuroscience. 12: 569.
43. WELLER, M., A. M. MARINI, B. MARTIN, and A. M. PAUL. 1994. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons. J. of Pharmacolog and Exp. Therapeutics 268: 393.
44. BLAIR, J. A., and A. J. PEARSON. 1973. A kinetic study of the autooxidation of tetrahydrobiopterin. Tetrahedron Lett. 3: 203.
45. MILSTIEN, S., N. SAKAI, B. J. BREW, C. KRIEGER, J. H. VICKERS, K. SAITO, and M. P. HEYES. 1994. Cerebrospinal fluid nitrite/nitrate levels in neurological diseases. J. of Neurochemistry 63: 1178.
46. BILLIAU, A., and R. DIJKMANS. 1990. Interferon-gamma: mechanisms of action and therapeutic potential. Biochem. Pharmacol. 40: 1433.
47. MURR, C., D. FUCHS, W. GÖSSLER, A. HAUSEN, G. REIBNEGGER, E. R. WERNER, G. WERNER-FELMAYER, H. ESTERBAUER, and H. WACHTER. 1994. Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. FEBS Let. 338: 223.
48. BAIER-BITTERLICH, G., G. BAIER, D. FUCHS, G. BÖCK, A. HAUSEN, G. UTERMANN, M. PAVELKA, and H. WACHTER. 1996. Role of 7,8-dihydroneopterin in T-cell apoptosis and HTLV-1 transcription in vitro. Oncogene 13: 2281.